Fitch Rtgs: US Pharma M&A, Portfolio Reshaping, R&D Offset Growth Risk - Fitch Research

Fitch Rtgs: US Pharma M&A, Portfolio Reshaping, R&D Offset Growth Risk

Fitch Rtgs: US Pharma M&A, Portfolio Reshaping, R&D Offset Growth Risk - Fitch Research
Fitch Rtgs: US Pharma M&A, Portfolio Reshaping, R&D Offset Growth Risk
Published Aug 15, 2019
1956 words — Published Aug 15, 2019
Price US$ 149.00  |  Buy this Report Now

About This Report

  
Brief Excerpt:

Link to Fitch Ratings' Report(s): U.S. Pharma M&A, Portfolio Reshaping and R&D Offset Growth Risk Fitch Ratings-Chicago-15 August 2019: U.S. pharmaceutical companies are making acquisitions, divesting assets, collaborating with joint...

  
Report Type:

Press Release

Company(ies)
Bristol-Myers Squibb Company , Merck & Co., Inc. , Pfizer Inc. , Eli Lilly and Company , Johnson & Johnson , Amgen Inc. , Mylan Inc , Teva Pharmaceutical Industries Ltd. , ALLERGAN UNLIMITED COMPANY , Teva Pharmaceuticals USA Inc. , Utah Acquisition Sub Inc
Issuer
Utah Acquisition Sub Inc.
Format:
HTML HTML
Buy Now

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author


Cite this Report

  
MLA:
Fitch Research. "Fitch Rtgs: US Pharma M&A, Portfolio Reshaping, R&D Offset Growth Risk" Aug 15, 2019. Alacra Store. May 13, 2025. <http://www.alacrastore.com/fitch-credit-research/Fitch-Rtgs-US-Pharma-M-A-Portfolio-Reshaping-R-D-Offset-Growth-Risk-PR_10086363>
  
APA:
Fitch Research. (2019). Fitch Rtgs: US Pharma M&A, Portfolio Reshaping, R&D Offset Growth Risk Aug 15, 2019. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/fitch-credit-research/Fitch-Rtgs-US-Pharma-M-A-Portfolio-Reshaping-R-D-Offset-Growth-Risk-PR_10086363>
  
US$ 149.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.